focusIR Fireside Chats podcast - FTSE 250 Fund Manager Reveals Hidden Emerging Market Gems | Infrastructure. Watch here

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: BB Healthcare acknowledges claims against director

Fri, 08th Oct 2021 06:48

BB Healthcare Trust PLC - London-based investor in healthcare business - Acknowledges recent press coverage of findings by a General Medical Council statutory committee against Justin Stebbing, oncologist at Imperial College London and BB Healthcare director, for providing "inappropriate treatment" to 12 terminally-ill cancer patients.

Advises a further announcement will be made when it has more information.

Current stock price: 193.00 pence

Year-to-date change: up 8.7%

By Josie O'Brien; josieobrien@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.


Shares in this article

Related News

TRADING UPDATES: Threadneedle invests GBP18.68 million in Bellevue
10 Mar 2026

TRADING UPDATES: Threadneedle invests GBP18.68 million in Bellevue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Funds Physiomics + 3 more shares
TRADING UPDATES: Helix acquires US acreage amid helium "crisis"
6 Mar 2026

TRADING UPDATES: Helix acquires US acreage amid helium "crisis"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

EARNINGS AND TRADING: Gelion loss narrows; Brave Bison in System1 deal
2 Mar 2026

EARNINGS AND TRADING: Gelion loss narrows; Brave Bison in System1 deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

Corporate News Gelion + 8 more shares